-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Society News
-
Committee Update: Advocates Offer Unique Support to Members, Help Investigators Understand Patients
Patient Advocates Committee Chair Jill Feldman said ensuring the patient voice is present in research helps to improve the work being done to reduce the burden of lung cancer worldwide.
-
In Brief for January 25, 2023
China approves mobocertinib for patients with EGFR Exon20 insertion+ NSCLC; Deadline approaching for IASLC 2023 Lectureship and Distinguished Service Award Nominations.
-
IASLC Announces New JTO CRR Editor-in-Chief
Dr. Emily Stone will succeed JTO Clinical and Research Reports founding editor Dr. Alex A. Adjei, who will remain editor-in-chief of the Journal of Thoracic Oncology.
-
ILCN Names New Associate Editors
Long-time editorial group members, Drs. Mary Jo Fidler, Witold Rzyman, and Suresh Senan bring disciplinary diversity to ILCN’s leadership.
-
In Brief for Dec. 21, 2022
IASLC names J. Michael Hoehn COO. FDA approves adagrasib for KRAS G12C-mutated NSCLC. NHS England increases access to screening in effort to catch cancers earlier.
-
In Brief for Nov. 9, 2022
Go2 Foundation coordinates educational events across the United States to improve lung cancer awareness; abstract submissions open for 2023 European Lung Cancer Congress; and registration begins for inaugural Texas Lung Cancer Conference.
-
In Brief for Oct. 26, 2022
Upcoming IASLC meetings offer educational opportunities around the globe. Read more for registration and abstract news from LACLC, ACLC, and TTLC.
-
In Brief for June 8, 2022
Abstract submission deadlines are approaching for the Asia Conference on Lung Cancer and the North America Conference on Lung Cancer.
-
Renowned Researcher Fred Hirsch Delivers 2022 Heine H. Hansen Award Lecture
The honor of giving the opening keynote address during ELCC recognizes Dr. Hirsch’s significant contributions to international research and education.
-
In Brief for May 25, 2022
5th edition of patient education book released; US FDA moves to prohibit tobacco flavoring.